國立高雄大學圖資館 |

Language: English

Back

Drug resistance in leishmania parasi...

Padron-Nieves, Maritza.

Drug resistance in leishmania parasitesconsequences, molecular mechanisms and possible treatments /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Drug resistance in leishmania parasitesedited by Alicia Ponte-Sucre, Maritza Padron-Nieves.
Reminder of title:	consequences, molecular mechanisms and possible treatments /
other author:	Ponte-Sucre, Alicia.
Published:	Cham :Springer International Publishing :2018.
Description:	xvii, 376 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Leishmaniasis.
Online resource:	http://dx.doi.org/10.1007/978-3-319-74186-4
ISBN:	9783319741864$q(electronic bk.)

Drug resistance in leishmania parasitesconsequences, molecular mechanisms and possible treatments /
Drug resistance in leishmania parasitesconsequences, molecular mechanisms and possible treatments /[electronic resource] :edited by Alicia Ponte-Sucre, Maritza Padron-Nieves. - 2nd ed. - Cham :Springer International Publishing :2018. - xvii, 376 p. :ill., digital ;24 cm.

Prologue -- Introduction -- Part I Determinant features in Leishmaniasis -- Molecular evolution and phylogeny of Leishmania -- The role of reservoirs: canine Leishmaniasis -- Epidemiology of Leishmaniasis in the time of drug resistance -- The role of the immune system in resistance to infection -- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance -- Co-infection with HIV -- Visceral Leishmaniasis -- Tegumentary Leishmaniasis -- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis -- Part III Molecular featrues of drug resistant Leishmania -- Genetic Expression and drug resistance, the role of proteomics -- The role of AMC transporters in drug-resistant Leishmania -- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance -- Part IV Pharmacology and chemotherapy of Leishmaniasis -- Classical vs. novel treatment regimens -- Bioinformatics in Leishmania drug design -- Leishmanis mitochondria, a druggable organelle -- P-glycoprotein-like transporters in Leishmania: a search for reversal agents -- Part V Strategies to circumvent drug resistance in Leishmania -- The relevance of susceptibility tests, breakpoints and markers -- The concept of fitness in Leishmania.

Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on the concept of parasitic drug resistance, its molecular basis, consequences and possible treatments. A valuable resource for scientists both from academia and industry involved in biomedical research and drug design, the book provides the knowledge needed to understand leishmaniasis and to contibute to combatting this disease worldwide.

ISBN: 9783319741864$q(electronic bk.)

Standard No.: 10.1007/978-3-319-74186-4doiSubjects--Topical Terms:

676734
Leishmaniasis.

LC Class. No.: RC153 / .D784 2018

Dewey Class. No.: 616.9364

Drug resistance in leishmania parasitesconsequences, molecular mechanisms and possible treatments /
LDR:02972nmm a2200325 a 4500 001 543569
003 DE-He213
005 20190225094126.0
006 m d
007 cr nn 008maaau
008 190430s2018 gw s 0 eng d
020 $a 9783319741864$q(electronic bk.)
020 $a 9783319741857$q(paper)
024 7 $a 10.1007/978-3-319-74186-4 $2 doi
035 $a 978-3-319-74186-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC153 $b .D784 2018
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
082 0 4 $a 616.9364 $2 23
090 $a RC153 $b .D794 2018
245 0 0 $a Drug resistance in leishmania parasites $h [electronic resource] : $b consequences, molecular mechanisms and possible treatments / $c edited by Alicia Ponte-Sucre, Maritza Padron-Nieves.
250 $a 2nd ed.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a xvii, 376 p. : $b ill., digital ; $c 24 cm.
505 0 $a Prologue -- Introduction -- Part I Determinant features in Leishmaniasis -- Molecular evolution and phylogeny of Leishmania -- The role of reservoirs: canine Leishmaniasis -- Epidemiology of Leishmaniasis in the time of drug resistance -- The role of the immune system in resistance to infection -- Part II Challenges in the diagnosis, treatment and control of Leishmaniasis in the times of drug resistance -- Co-infection with HIV -- Visceral Leishmaniasis -- Tegumentary Leishmaniasis -- Antimony accounted sequel post Kala-Azar dermal Leishmaniasis -- Part III Molecular featrues of drug resistant Leishmania -- Genetic Expression and drug resistance, the role of proteomics -- The role of AMC transporters in drug-resistant Leishmania -- Functional analysis of Leishmania membrane (non AMC) transporters involved in drug resistance -- Part IV Pharmacology and chemotherapy of Leishmaniasis -- Classical vs. novel treatment regimens -- Bioinformatics in Leishmania drug design -- Leishmanis mitochondria, a druggable organelle -- P-glycoprotein-like transporters in Leishmania: a search for reversal agents -- Part V Strategies to circumvent drug resistance in Leishmania -- The relevance of susceptibility tests, breakpoints and markers -- The concept of fitness in Leishmania.
520 $a Drug resistance is a fundamental factor in treatment failure in diseases like leishmaniasis, although additional factors also play a role in this phenomenon. This volume is the second edition of a well-received book that provides a comprehensive update on the pathology of the disease, as well as on the concept of parasitic drug resistance, its molecular basis, consequences and possible treatments. A valuable resource for scientists both from academia and industry involved in biomedical research and drug design, the book provides the knowledge needed to understand leishmaniasis and to contibute to combatting this disease worldwide.
650 0 $a Leishmaniasis. $3 676734
650 0 $a Drug resistance in microorganisms. $3 192960
650 0 $a Medical parasitology. $3 196503
650 1 4 $a Biomedicine. $3 273648
650 2 4 $a Drug Resistance. $3 338425
650 2 4 $a Infectious Diseases. $3 274275
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Vaccine. $3 337782
650 2 4 $a Parasitology. $3 194533
650 2 4 $a Microbiology. $3 192943
700 1 $a Ponte-Sucre, Alicia. $3 821836
700 1 $a Padron-Nieves, Maritza. $3 821837
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-74186-4
950 $a Biomedical and Life Sciences (Springer-11642)